Trinity Biotech (TRIB) EPS (Weighted Average and Diluted) (2021 - 2022)
Trinity Biotech recorded quarterly EPS (Weighted Average and Diluted) of -$51.08 in Q2 2022, down 160.97% quarter-over-quarter from -$19.58 in Q2 2021, and down 160.97% year-over-year from $83.79 in Q2 2021.
Trinity Biotech's EPS (Weighted Average and Diluted) history runs 2 years deep, the most recent figure standing at -$51.08 for Q2 2022.
- In Q2 2022, EPS (Weighted Average and Diluted) fell 160.97% year-over-year to -$51.08; the TTM figure through Jun 2022 stood at -$51.08 (down 160.97% YoY), while the FY2025 annual figure was -$2.0, down 11.11% from the prior year.
- EPS (Weighted Average and Diluted) came in at -$51.08 for Q2 2022 at Trinity Biotech, down from -$19.58 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of -$19.58 in Q2 2021 to a low of -$51.08 in Q2 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.61 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.93 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.89 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.90 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.66 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 0.51 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.85 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 2.24 |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2022 | -51.08 |
| Jun 30, 2021 | -19.58 |